<DOC>
	<DOCNO>NCT02615626</DOCNO>
	<brief_summary>The purpose study evaluate visfatin level different stage periodontal diseases health , moreover effect non-surgical periodontal therapy visfatin level Gingival Crevicular Fluid ( GCF ) Serum .</brief_summary>
	<brief_title>Visfatin Levels Before After Periodontal Treatment</brief_title>
	<detailed_description>Total 45 patient divide three group base clinical radiographical examination . Group 1 chronic periodontitis ( n : 15 ) , group 2 plaque induce gingivitis ( n : 15 ) group 3 Periodontal health ( n : 15 ) . GCF serum sample collect treatment 1 , 3 , 6 month treatment assay use enzyme link immunosorbent assay kit .</detailed_description>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<criteria>Group 1 GI &gt; 1 , PPD≥5mm , CAL≥5mm alveolar bone loss radiographically . Systematically healthy patient Group 2 No alveolar bone attachment loss Inflammation sign redness , edema increase BOP level , GI≥2 , PPD≤3mm , CAL≤3mm . Systematically healthy patient Group 3 No bone attachment loss , GI=0 , PPD≤3mm , CAL≤3mm Systematically healthy patient Exclusion Criteria group : Aggressive Periodontitis , Oral pathology , Patients systemic disease , Pregnant woman lactation period , Patients smoke habit take medication Patients receive periodontal therapy last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Visfatin</keyword>
	<keyword>GCF</keyword>
	<keyword>serum</keyword>
	<keyword>Non-surgical Periodontal Treatment .</keyword>
</DOC>